Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 05-Aug-24 4:13 PM View:  | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Alkermes Plc. (ALKS) | 03-Aug-24 | Payment of Exercise | 895 | $27.72 | $24,809.40 | (< 1%) 166.8K to 165.9K | |
| 05-Aug-24 4:13 PM View: | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Alkermes Plc. (ALKS) | 03-Aug-24 | Option Exercise | 2,014 | -- | -- | 1% 164.78K to 166.8K | |
| 01-Jul-24 4:59 PM View: | McKeon Brian P Director | Alkermes Plc. (ALKS) | 29-Jun-24 | Option Exercise | 6,104 | -- | -- | 18% 33.14K to 39.24K | |
| 01-Jul-24 4:58 PM View: | Laurencin Cato T Director | Alkermes Plc. (ALKS) | 29-Jun-24 | Option Exercise | 6,104 | -- | -- | 40% 15.17K to 21.27K | |
| 01-Jul-24 5:01 PM View: | Snyderman Nancy Lynn Md Director | Alkermes Plc. (ALKS) | 29-Jun-24 | Payment of Exercise | 1,465 | $24.10 | $35,306.50 | (5%) 26.89K to 25.42K | |
| 01-Jul-24 4:55 PM View: | Gaynor Richard Director | Alkermes Plc. (ALKS) | 29-Jun-24 | Payment of Exercise | 1,465 | $24.10 | $35,306.50 | (6%) 26.46K to 25.0K | |
| 01-Jul-24 5:04 PM View: | Wright Christopher I Director | Alkermes Plc. (ALKS) | 29-Jun-24 | Payment of Exercise | 1,465 | $24.10 | $35,306.50 | (9%) 15.88K to 14.42K | |
| 01-Jul-24 5:01 PM View: | Snyderman Nancy Lynn Md Director | Alkermes Plc. (ALKS) | 29-Jun-24 | Option Exercise | 6,104 | -- | -- | 29% 20.78K to 26.89K | |
| 01-Jul-24 4:55 PM View: | Gaynor Richard Director | Alkermes Plc. (ALKS) | 29-Jun-24 | Option Exercise | 6,104 | -- | -- | 30% 20.36K to 26.46K | |
| 01-Jul-24 5:02 PM View: | Wilson Frank Anders Director | Alkermes Plc. (ALKS) | 29-Jun-24 | Payment of Exercise | 1,465 | $24.10 | $35,306.50 | (6%) 26.46K to 25.0K | |
| 01-Jul-24 4:59 PM View: | McKeon Brian P Director | Alkermes Plc. (ALKS) | 29-Jun-24 | Payment of Exercise | 1,465 | $24.10 | $35,306.50 | (4%) 39.24K to 37.78K | |
| 01-Jul-24 4:58 PM View: | Laurencin Cato T Director | Alkermes Plc. (ALKS) | 29-Jun-24 | Payment of Exercise | 1,465 | $24.10 | $35,306.50 | (7%) 21.27K to 19.81K | |
| 01-Jul-24 5:04 PM View: | Wright Christopher I Director | Alkermes Plc. (ALKS) | 29-Jun-24 | Option Exercise | 6,104 | -- | -- | 62% 9.78K to 15.88K | |
| 01-Jul-24 5:02 PM View: | Wilson Frank Anders Director | Alkermes Plc. (ALKS) | 29-Jun-24 | Option Exercise | 6,104 | -- | -- | 30% 20.36K to 26.46K | |
| 10-Jun-24 8:56 PM View: | Alva Emily Peterson Director | Alkermes Plc. (ALKS) | 09-Jun-24 | Option Exercise | 3,871 | -- | -- | 20% 19.72K to 23.59K | |
| 10-Jun-24 8:56 PM View: | Alva Emily Peterson Director | Alkermes Plc. (ALKS) | 09-Jun-24 | Payment of Exercise | 930 | $23.91 | $22,236.30 | (4%) 23.59K to 22.66K | |
| 10-Jun-24 8:55 PM View: | Wright Christopher I Director | Alkermes Plc. (ALKS) | 08-Jun-24 | Option Exercise | 3,301 | -- | -- | 45% 7.27K to 10.57K | |
| 10-Jun-24 8:55 PM View: | Wright Christopher I Director | Alkermes Plc. (ALKS) | 08-Jun-24 | Payment of Exercise | 793 | $23.91 | $18,960.60 | (8%) 10.57K to 9.78K | |
| 18-Mar-24 4:02 PM View: | Nichols Christian Todd SVP, Chief Commercial Officer | Alkermes Plc. (ALKS) | 18-Mar-24 | Private Sale (Planned) | 10,417 | $28.10 | $292,740.00 | (14%) 76.33K to 65.91K | |
| 27-Feb-24 4:09 PM View: | Parisi Samuel Joseph VP, Finance (Interim PAO) | Alkermes Plc. (ALKS) | 27-Feb-24 | Sale | 276 | $29.65 | $8,183.40 | (3%) 7.99K to 7.72K | |
| 27-Feb-24 4:09 PM View: | Parisi Samuel Joseph VP, Finance (Interim PAO) | Alkermes Plc. (ALKS) | 27-Feb-24 | Option Sale | 2,283 | $29.65 | $67,690.90 | (22%) 10.28K to 7.99K | |
| 27-Feb-24 4:03 PM View: | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Alkermes Plc. (ALKS) | 23-Feb-24 | Option Exercise | 7,689 | -- | -- | 7% 105.43K to 113.12K | |
| 27-Feb-24 4:11 PM View: | Nichols Christian Todd SVP, Chief Commercial Officer | Alkermes Plc. (ALKS) | 23-Feb-24 | Option Exercise | 6,407 | -- | -- | 9% 72.77K to 79.17K | |
| 27-Feb-24 4:04 PM View: | Jackson Blair Curtis EVP, Chief Operating Officer | Alkermes Plc. (ALKS) | 23-Feb-24 | Option Exercise | 8,737 | -- | -- | 6% 152.94K to 161.68K | |
| 27-Feb-24 4:07 PM View: | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Alkermes Plc. (ALKS) | 23-Feb-24 | Option Exercise | 7,689 | -- | -- | 5% 160.51K to 168.2K | |
| 27-Feb-24 4:09 PM View: | Parisi Samuel Joseph VP, Finance (Interim PAO) | Alkermes Plc. (ALKS) | 23-Feb-24 | Payment of Exercise | 672 | $29.57 | $19,871.00 | (6%) 10.95K to 10.28K | |
| 27-Feb-24 4:06 PM View: | Landine Michael J SVP, Corp Dev., Alkermes, Inc. | Alkermes Plc. (ALKS) | 23-Feb-24 | Payment of Exercise | 1,811 | $29.57 | $53,551.30 | (< 1%) 283.54K to 281.73K | |
| 27-Feb-24 4:08 PM View: | Brown Iain Michael SVP, Chief Financial Officer | Alkermes Plc. (ALKS) | 23-Feb-24 | Payment of Exercise | 2,587 | $29.57 | $76,497.60 | (2%) 118.93K to 116.34K | |
| 27-Feb-24 4:09 PM View: | Parisi Samuel Joseph VP, Finance (Interim PAO) | Alkermes Plc. (ALKS) | 23-Feb-24 | Option Exercise | 2,283 | -- | -- | 26% 8.66K to 10.95K | |
| 27-Feb-24 4:06 PM View: | Landine Michael J SVP, Corp Dev., Alkermes, Inc. | Alkermes Plc. (ALKS) | 23-Feb-24 | Option Exercise | 4,077 | -- | -- | 1% 279.46K to 283.54K | |
| 27-Feb-24 4:03 PM View: | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Alkermes Plc. (ALKS) | 23-Feb-24 | Payment of Exercise | 3,414 | $29.57 | $100,952.00 | (3%) 113.12K to 109.71K | |
| 27-Feb-24 4:11 PM View: | Nichols Christian Todd SVP, Chief Commercial Officer | Alkermes Plc. (ALKS) | 23-Feb-24 | Payment of Exercise | 2,845 | $29.57 | $84,126.60 | (4%) 79.17K to 76.33K | |
| 27-Feb-24 4:04 PM View: | Jackson Blair Curtis EVP, Chief Operating Officer | Alkermes Plc. (ALKS) | 23-Feb-24 | Payment of Exercise | 3,880 | $29.57 | $114,732.00 | (2%) 161.68K to 157.8K | |
| 27-Feb-24 4:07 PM View: | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Alkermes Plc. (ALKS) | 23-Feb-24 | Payment of Exercise | 3,414 | $29.57 | $100,952.00 | (2%) 168.2K to 164.78K | |
| 27-Feb-24 4:08 PM View: | Brown Iain Michael SVP, Chief Financial Officer | Alkermes Plc. (ALKS) | 23-Feb-24 | Option Exercise | 5,825 | -- | -- | 5% 113.11K to 118.93K | |
| 23-Feb-24 4:04 PM View: | Brown Iain Michael SVP, Chief Financial Officer | Alkermes Plc. (ALKS) | 22-Feb-24 | Payment of Exercise | 3,156 | $28.91 | $91,240.00 | (3%) 116.26K to 113.11K | |
| 23-Feb-24 4:14 PM View: | Parisi Samuel Joseph VP, Finance (Interim PAO) | Alkermes Plc. (ALKS) | 22-Feb-24 | Option Exercise | 3,114 | -- | -- | 48% 6.46K to 9.57K | |
| 23-Feb-24 4:10 PM View: | Landine Michael J SVP, Corp Dev., Alkermes, Inc. | Alkermes Plc. (ALKS) | 22-Feb-24 | Option Exercise | 5,654 | -- | -- | 2% 275.74K to 281.39K | |
| 23-Feb-24 4:07 PM View: | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Alkermes Plc. (ALKS) | 22-Feb-24 | Payment of Exercise | 5,452 | $28.91 | $157,617.00 | (5%) 110.89K to 105.43K | |
| 23-Feb-24 4:13 PM View: | Nichols Christian Todd SVP, Chief Commercial Officer | Alkermes Plc. (ALKS) | 22-Feb-24 | Payment of Exercise | 3,156 | $28.91 | $91,240.00 | (4%) 75.92K to 72.77K | |
| 23-Feb-24 4:09 PM View: | Jackson Blair Curtis EVP, Chief Operating Officer | Alkermes Plc. (ALKS) | 22-Feb-24 | Payment of Exercise | 4,304 | $28.91 | $124,429.00 | (3%) 157.25K to 152.94K | |
| 23-Feb-24 4:05 PM View: | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Alkermes Plc. (ALKS) | 22-Feb-24 | Payment of Exercise | 3,300 | $28.91 | $95,403.00 | (2%) 163.81K to 160.51K | |
| 23-Feb-24 4:04 PM View: | Brown Iain Michael SVP, Chief Financial Officer | Alkermes Plc. (ALKS) | 22-Feb-24 | Option Exercise | 7,108 | -- | -- | 7% 109.15K to 116.26K | |
| 23-Feb-24 4:07 PM View: | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Alkermes Plc. (ALKS) | 22-Feb-24 | Option Exercise | 12,278 | -- | -- | 12% 98.61K to 110.89K | |
| 23-Feb-24 4:13 PM View: | Nichols Christian Todd SVP, Chief Commercial Officer | Alkermes Plc. (ALKS) | 22-Feb-24 | Option Exercise | 7,108 | -- | -- | 10% 68.81K to 75.92K | |
| 23-Feb-24 4:09 PM View: | Jackson Blair Curtis EVP, Chief Operating Officer | Alkermes Plc. (ALKS) | 22-Feb-24 | Option Exercise | 9,693 | -- | -- | 7% 147.56K to 157.25K | |
| 23-Feb-24 4:05 PM View: | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Alkermes Plc. (ALKS) | 22-Feb-24 | Option Exercise | 7,431 | -- | -- | 5% 156.38K to 163.81K | |
| 23-Feb-24 4:14 PM View: | Parisi Samuel Joseph VP, Finance (Interim PAO) | Alkermes Plc. (ALKS) | 22-Feb-24 | Payment of Exercise | 908 | $28.91 | $26,250.30 | (9%) 9.57K to 8.66K | |
| 23-Feb-24 4:10 PM View: | Landine Michael J SVP, Corp Dev., Alkermes, Inc. | Alkermes Plc. (ALKS) | 22-Feb-24 | Payment of Exercise | 1,929 | $28.91 | $55,767.40 | (< 1%) 281.39K to 279.46K | |
| 21-Feb-24 5:32 PM View: | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Alkermes Plc. (ALKS) | 20-Feb-24 | Payment of Exercise | 4,572 | $30.39 | $138,943.00 | (4%) 103.18K to 98.61K |
